Skip to main content
Johannes Van Den Anker

Pediatrics

Johannes Van Den Anker, MD

Division Chief of Clinical Pharmacology; Vice Chair of Experimental Therapeutics; Evan and Cindy Jones Professor, Pediatric Clinical Pharmacology

Washington, DC

Johannes N. van den Anker, MD, PhD, is a renowned pediatric clinical pharmacologist specializing in neonatal and pediatric pharmacology, serving primarily neonates, young infants, and children at Children's National Hospital in Washington, DC. He focuses on developmental and neonatal clinical pharmacology of critical medications, including antibacterial agents such as aminoglycosides, cephalosporins, penicillins, meropenem, and vancomycin, as well as analgesics like fentanyl, morphine, and ibupr

...

19+

Years in Practice

Credentials

Board Certifications

  • Neonatal-Perinatal Medicine (ABMS)

Education & Training

  • Erasmus University, Rotterdam — M.D. and Ph.D. in Clinical Pharmacology
  • Erasmus University / Sophia Children’s Hospital, Rotterdam — Residency in Pediatrics and Fellowship in Neonatal Medicine

Recognition & Leadership

Leadership Roles

  • Vice Chair of Experimental Therapeutics

Clinical Focus

Subspecialties

Neonatal-Perinatal Medicine

Conditions & Treatments

Neonatal Intensive CareNeonatal Pharmacology

Practice Details

Hospital Affiliations

  • Children's National Hospital

Languages

English

Experience

19+ years in practice